08:30-09:50		Registration & Welcome Coffee

08:50-09:50		Podium Session (non-moderated)

09:50-10:00		Opening Remarks Jae-Young JOUNG (President, KPS) Seong Il SEO (President, KUA)

Session 1. Active Surveillance for Prostate Cancer
Time	10:00-11:00
Chair(s)	Jae Il CHUNG (Korea) Takashi FUKAGAI (Japan) Tuan Vinh NGUYEN (Vietnam)
Speaker(s)	10:00-10:10	Active surveillance in 2026: eligibility and risk reclassification (GG1–selected GG2) Won Hoon SONG (Korea)
	10:10-10:20	Integrating mpMRI and PSA kinetics: practical triggers for repeat biopsy and treatment Hung Jen WANG (Taiwan)
	10:20-10:30	The Pan-Prostate Genomics Consortium: Who are we, what we do, and what have we found Niall CORCORAN (Australia)
	10:30-11:00	Case-based discussion: young patient, high PSA density, MRI change—continue AS or treat? Moderator: Byung Hoon KIM (Korea) Discussant: Jae Heon KIM (Korea)   /   Yun Beom KIM (Korea)   /   Won Hoon SONG (Korea)   /   Hung Jen WANG (Taiwan)   /   Niall CORCORAN (Australia)

11:00-11:20		Coffee Break

Session 2. Locally Advanced Prostate Cancer
Time	11:20-12:30
Chair(s)	Seong Il SEO (Korea) Jacob ST PANG (Taiwan)
Speaker(s)	11:20-11:30	Staging locally advanced disease in the PSMA PET era: what changes in 2026? Jing Ren TSENG (Taiwan)
	11:30-11:40	Multimodal local therapy: surgery vs radiotherapy + ADT ± AR pathway inhibitor Jong Wook KIM (Korea)
	11:40-11:50	Neoadjuvant systemic therapy before radical prostatectomy: current evidence and ongoing trials Isaac KIM (USA)
	11:50-12:20	Case-based discussion: cT3b / N1 with high PSA—sequencing local and systemic therapy Moderator: Seong Hyeon YU (Korea) Discussant: Gyeong Eun MIN (Korea)   /   Won Tae KIM (Korea)   /   Jing Ren TSENG (Taiwan)   /   Jong Wook KIM (Korea)   /   Isaac KIM (USA)   /   Ngoc Hung PHAM (Vietnam)

Lunch & Luncheon Symposium sponsored by Astellas
Time	12:20-13:30
Chair(s)	U Syn HA (Korea)
Speaker(s)	12:20-12:40	Optimizing Patient Care in Hormone-Sensitive Prostate Cancer and Future Directions Amit BAHL (UK)

Session 3. Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Time	13:30-14:40
Chair(s)	Ji Youl LEE (Korea) Hiroji UEMURA (Japan)
Speaker(s)	13:30-13:45	The Art of Selecting the Right Intensity: A Tailored Approach to Doublet and Triplet Therapies in mHSPC Silke GILLESSEN (Swiss)
	13:45-13:55	Beyond the Class Effect: A Clinician's Guide to ARPI Selection and Toxicity Tailoring in mHSPC Joseph KIM (USA)
	13:55-14:05	Radiotherapy to the primary and metastasis-directed therapy: who benefits and how to integrate Jung Ki JO (Korea)
	14:05-14:15	Monitoring response and resistance: imaging, biomarkers, and when to change strategy Lukman HAKIM (Indonesia)
	14:15-14:40	Case-based discussion: de novo low-volume disease with cardiovascular comorbidity—what would you start? Moderator: Sang Hun SONG (Korea) Discussant: Dalsan YOU (Korea)   /   Jae Seung CHUNG (Korea)   /   Silke GILLESSEN (Swiss)   /   Joseph KIM (USA)   /   Jung Ki CHO (Korea)   /   Lukman HAKIM (Indonesia)

Satellite symposium sponsored by JnJ Innovative Medicine
Time	14:40-15:00
Chair(s)	Jae Seung CHUNG (Korea)
Speaker(s)	14:40-15:00	Navigating mHSPC: Clinical Evidence Highlighting Apalutamide's Impact on Overall Survival Jung Ki JO (Korea)

15:00-15:30		Coffee Break

Session 4. Focal Therapy for Localized Prostate Cancer
Time	15:30-16:40
Chair(s)	Hyunglae LEE (Korea) Peter K.F. CHIU (Hong Kong)
Speaker(s)	15:30-15:40	Patient selection for focal therapy: mapping biopsy, MRI, and defining clinically significant disease Kuan Chou CHEN (Taiwan)
	15:40-15:50	Mastering the Middle Ground: Long-term Clinical Insights and Technical Pearls of Focal HIFU Sunao SHOJI (Japan)
	15:50-16:00	A new era in prostate cancer treatment: focal therapy with transperineal irreversible electroporation Wai Kit MA (Hong Kong)
	16:00-16:10	Salvage after focal therapy failure: surgery vs radiation—technical tips and outcomes Younsoo CHUNG (Korea)
	16:10-16:40	Case-based discussion: anterior lesion, multifocal disease, and salvage after failed HIFU Moderator: Yong Hyun PARK (Korea) Discussant: Phil Hyun SONG (Korea)   /   Kuan Chou CHEN (Taiwan)   /   Sunao SHOJI (Japan)   /   Wai Kit MA (Hong Kong)   /   Younsoo CHUNG (Korea)

16:40-16:50		Day 1 Closing / Announcements

08:30-09:00		Registration & Welcome Coffee

09:00-09:10		Day 2 Opening / Highlights

Session 5. Prostate Biopsy for Prostate Cancer Diagnosis
Time	09:10-10:20
Chair(s)	Byung Kwan PARK (Korea) Moon Ki JO (Korea)
Speaker(s)	09:10-09:20	Transperineal biopsy as the new standard: technique, anesthesia, and infection prevention Dongho SHIN (Korea)
	09:20-09:30	Fusion biopsy platforms and workflow: cognitive vs software fusion—what changes outcomes? Peter K.F. CHIU (Hong Kong)
	09:30-09:40	How many systematic cores in the mpMRI era? Balancing detection vs overdiagnosis Jang Hee HAN (Korea)
	09:40-09:50	PSMA PET and next-generation imaging: implications for diagnosis and staging pathways Jing-Ren TSENG (Taiwan)
	09:50-10:20	Case-based discussion: prior negative biopsy, PI-RADS 3–5 lesions, anticoagulation, and infection risk Moderator: Jae Hyun RYU (Korea) Discussant: Duc Minh PHAM (Vietnam)   /   Jong Kil NAM (Korea)   /   Dongho SHIN (Korea)   /   Peter K.F. CHIU (Hong Kong)   /   Jang Hee HAN (Korea)   /   Jing-Ren TSENG (Taiwan)

10:20-10:50		Coffee Break

Session 6. Surgical Treatment for Localized Prostate Cancer
Time	10:50-12:00
Chair(s)	Jun Hyuk HONG (Korea) Teng Aik ONG (Malaysia)
Speaker(s)	10:50-11:00	Nerve-sparing in high-risk and apical disease: oncologic safety vs functional recovery Kazutoshi FUJITA (Japan)
	11:00-11:10	Pelvic lymph node dissection in 2026: templates, indications, and emerging guidance tools Young Hwi KO (Korea)
	11:10-11:20	Continence and sexual function recovery: prehab/rehab strategies and patient counseling Wai Kit MA (Hong Kong)
	11:20-11:30	Technical hot topics in RARP: bladder neck, posterior reconstruction, and complication prevention Soodong KIM (Korea)
	11:30-12:00	Case-based discussion: large prostate, prior TURP, MRI T3a suspicion—how would you plan surgery? Moderator: Se Young CHOI (Korea) Discussant: Taek Sang KIM (Korea)   /   Hongzoo PARK (Korea)   /   Kazutoshi FUJITA (Japan)   /   Young Hwi KO (Korea)   /   Wai Kit MA (Hong Kong)   /   Soodong KIM (Korea)

Lunch / Luncheon Symposium sponsored by Bayer
Time	12:00-13:00
Chair(s)	Hwang Gyun JEON (Korea)
Speaker(s)	12:00-12:20	Balancing Efficacy and Favourable Tolerability with Darolutamide-based Regimen Niall CORCORAN (Australia)

Session 7. Metastatic Castration-resistant Prostate Cancer (mCRPC)
Time	13:00-14:10
Chair(s)	Sung Kyu HONG (Korea) Edmund CHIONG (Singapore)
Speaker(s)	13:00-13:15	Beyond the Crossroads: Expert Consensus on Optimal Sequencing after First-Line ARPI failure Silke GILLESSEN (Swiss)
	13:15-13:25	Refining the mCRPC Treatment Algorithm: The Strategic Integration of PSMA-RLT Pre- and Post-Taxane Amit BAHL (UK)
	13:25-13:35	Biomarker-driven therapy: PARP inhibitors, HRR alterations, MSI-H, and testing strategies Joseph KIM (USA)
	13:35-13:45	Supportive care as disease-modifying care: bone protection, pain, frailty, and QoL metrics Kinh Luan THAI (Vietnam)
	13:45-14:10	Case-based discussion: PSMA+/FDG discordance, BRCA2 mutation, post-docetaxel—what next? Moderator: Bum Sik TAE (Korea) Discussant: Sangchul LEE (Korea)   /   Yu Seob SHIN (Korea)   /   Silke GILLESSEN (Swiss)   /   Amit BAHL (UK)   /   Joseph KIM (USA)   /   Kinh Luan THAI (Vietnam)

Satellite symposium sponsored by Novartis
Time	14:10-14:30
Chair(s)	Taek Won KANG (Korea)
Speaker(s)	14:10-14:30	From VISION to Real-World: Practical Insights on Implementing PSMA Radioligand Therapy Yu-Yi HUANG (Taiwan)

14:30-15:00		Coffee Break

Session 8. Surgical Treatment of Benign Prostatic Hyperplasia (BPH)
Time	15:00-16:10
Chair(s)	Tag Keun YOO (Korea) Phuc Cam Hoang NGUYEN (Vietnam)
Speaker(s)	15:00-15:10	Minimally invasive surgical therapies for BPH: Current landscape and evidence Seyun KWON (Korea)
	15:10-15:20	Prostatic urethral lift and temporary implants: Who truly benefits? Joong Ho LEE (Korea)
	15:20-15:30	Water vapor and thermal therapies for BPH: Rezum and beyond Se Young CHOI (Korea)
	15:30-15:40	Endoscopic enucleation vs minimally invasive surgery: Where do we draw the line? Byung Kyu HAN (Korea)
	15:40-16:10	Case-based discussion Moderator: Yun Sok HA (Korea) Discussant: Won Ik SEO (Korea)   /   Sang Wook LEE (Korea)   /   Seyun KWON (Korea)   /  Joong Ho LEE (Korea)   /   Se Young CHOI (Korea)   /   Byung Kyu HAN (Korea)

16:10-16:30		General meeting

16:30-16:40		Closing Ceremony